Bye-bye painful dentist visit: A simple liquid could stop tooth decay; no drilling or injections needed for many cavities

For anyone who has ever white-knuckled their way through a dentist's chair, a new study out of the United States has some genuinely good news.

A liquid that can be painted onto a cavity in seconds, with no drilling, no injections, and no sedation, has been shown in a major clinical trial to stop tooth decay in more than half of treated baby teeth. The treatment, called silver diamine fluoride or SDF, has been around for decades in other parts of the world. What the new study provides, for the first time, is the kind of large-scale American clinical evidence that could push it from a fringe workaround into mainstream dental care.

The findings were published on 29 July in JAMA Pediatrics.


Silver Diamine Fluoride Tooth Decay Treatment

SDF is not new. Dentists in Japan, Australia, and parts of Latin America have been using it for decades. In the United States, it has been available since 2014, but only as an off-label treatment approved for reducing tooth sensitivity, not officially for treating cavities.

The way it works is straightforward. A dentist or healthcare provider dips a small sponge-tipped applicator into the liquid and brushes it directly onto the decayed part of the tooth. The whole process takes a few seconds per tooth. The silver in the formula kills the bacteria driving the decay, and the fluoride helps harden the remaining tooth structure.

No drilling. No anaesthesia. No child screaming in the chair.

University of Michigan Dental Study

The Phase III clinical trial was led by Margherita Fontana, professor of dentistry at the University of Michigan School of Dentistry, and involved 830 children under the age of six. Participants were recruited through dental offices, paediatric medical practices, and Head Start programmes across Michigan, New York, and Iowa.

The trial ran from 2018 and continued through the disruptions of the Covid-19 pandemic, a detail that speaks to how seriously the researchers took seeing it through.

The results showed that 38 per cent SDF, applied every six months, stopped decay in more than half of the affected baby teeth. For a treatment that costs a fraction of conventional fillings and requires no specialised equipment beyond the applicator, that is a significant finding.

"This is a very effective and safe treatment, even in children as young as one," Fontana said.

No Drilling Cavity Treatment for Children

To understand why this matters, it helps to know how bad the current situation is.

Tooth decay is the most common chronic disease among children in the United States, affecting more than 40 per cent of American kids. Untreated cavities send thousands of young children to emergency departments every year. Hospital doctors, who are not dentists, typically cannot fix the underlying problem. So children go home, still in pain, still infected, and often end up back again. Some eventually need surgery under general anaesthesia just to have their teeth sorted.

This is not a small problem. It means missed school days, disrupted sleep, difficulty eating, and repeated trips to medical facilities for something that, in many cases, could have been stopped early.

SDF, applied during a routine paediatric visit, could intercept many of those cases before they spiral.

"Young children often see paediatricians years before they ever visit a dentist," Fontana noted. "Broader acceptance could allow many more cavities to be treated while a referral to a dental home is successful, and before they become painful, infected, or require surgery."

Painless Dentist Alternative for Anxiety and Disability

Beyond young children, the researchers highlighted several other groups who stand to benefit significantly.

Older adults, people with physical or developmental disabilities, patients with severe dental anxiety, and anyone in a region with limited access to conventional dental care are all candidates for whom SDF could be a practical, low-stress alternative to treatment they might otherwise avoid entirely.

For some patients, applying SDF every few months could manage a cavity until the baby tooth falls out on its own. In adults, it could serve as a longer-term solution or buy time until a more comprehensive procedure becomes affordable or accessible.

"For almost anyone, this can arrest the decay and stop the infection and the pain it causes," Fontana said. "This could benefit many people."

There is one visible trade-off. The silver in the liquid permanently darkens the decayed portion of the tooth, turning it black. For baby teeth that will eventually fall out anyway, many families consider this a reasonable exchange. For adults or for front teeth, it is a more complicated conversation.

SDF FDA Approval Cavities

The clinical trial was funded with more than 12 million dollars from the National Institute of Dental and Craniofacial Research, part of the US National Institutes of Health. Elevate Oral Care, the company behind the SDF product tested in the study, now has the clinical data it needs to submit a formal drug application to the FDA for approval of SDF as a cavity treatment.

That approval would be a meaningful shift. Right now, because SDF is off-label for cavities, insurance coverage is inconsistent and uptake among providers is uneven. An official FDA indication would change both of those things.

Amr Moursi, professor of paediatric dentistry at New York University College of Dentistry and a co-principal investigator on the study, put it plainly. "Removing SDF from off-label status would be an important innovation which could lead to increased utilisation by providers, enhanced payments by insurers and more consistent product quality," he said.

In other words, the science is there. The question now is whether the regulatory and insurance systems move quickly enough to get it to the people who need it.